In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 36191311.
- Also identified by DOI 10.7326/J22-0071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Farag HM, Yunusa I, Goswami H, et al. <b>Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis.</b> JAMA Netw Open. 2022;5:e2212939. 35587348.
Medical subject headings
- Amitriptyline
- Fibromyalgia